Navigation Links
Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
Date:9/12/2007

WASHINGTON, Sept. 12 /PRNewswire-USNewswire/ -- While the American College of Chest Physicians (ACCP) came out this week in opposition to CT screening for lung cancer, Lung Cancer Alliance (LCA) reiterated its support for the screening test which can detect lung cancer at its earliest most treatable stage for those at high risk.

"Mammograms for breast cancer faced enormous opposition for decades and there is still heated debate over screening of women under the age of 50. And there are reams of papers showing no mortality benefit for PSA testing for prostate cancer," said Laurie Fenton Ambrose, President of Lung Cancer Alliance.

"These scientific debates are not new, especially when it comes to interpreting statistics about the true benefit of screening," she said. "However it is disappointing and frankly shocking that the ACCP would flatly oppose CT screening for those at high risk for lung cancer when even the government health agency responsible for setting diagnostic guidelines is more balanced," she said.

The U.S. Preventive Services Task Force neither supports nor opposes screening for lung cancer, a neutral stance that it also takes on PSA testing for prostate cancer and breast self-exams for breast cancer.

"It is difficult to take the ACCP guidelines seriously when they are dismissive of screening and only endorse massages and acupuncture for a disease as deadly as lung cancer," she said.

The issue of early detection is critical in lung cancer which is the biggest cancer killer, taking more lives each year than breast, prostate, colon and kidney cancers combined. By the time symptoms, such as a cough or bloody sputum, appear it is usually too late and in most cases death occurs in less than a year.

Since last year, LCA has raised questions and concerns about the validity of underlying assumptions and modeling being used to provide the basis for the ACCP practice guidelines.

Harvey Pass MD, Chief of Thoracic Surgery and Thoracic Oncology at NYU School of Medicine, LCA Board member and chair of LCA's Medical and Scientific Advisory Board said: "These guidelines simply dismiss the mounting evidence which continues to mature from the largest international, protocol-driven screening effort (I-ELCAP) showing that CT screening in a high risk population has the potential to reverse the current 15% five year survival rate."

"Despite these guidelines, individuals at high risk for lung cancer should make it a personal choice after conferring with their doctors as to whether they want to participate in ongoing protocol-driven programs for the early detection of lung cancer using whatever means is being studied," he said.

"The fact is that hundreds of thousands of Americans have already discussed lung cancer screening options with their physicians. Many of those individuals have exercised their choice and consumed their personal resources in an informed decision to undergo spiral CT evaluation for the presence of an early lung cancer," Fenton-Ambrose noted.

"Recommending against CT screening for lung cancer, as ACCP does, is an extreme position that is out of step with current realities," she said.

"As an advocacy foundation committed to the well being of the many individuals at high risk for this lethal disease, we are committed to the aggressive expansion of effective tobacco control as well as for urgent development of responsible measures to advance early lung cancer detection measures. We are eager to work with all professional societies to advance this dialogue in a true evidence-based way to address the unremitting lethality of lung cancer," she said.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for people living with, or at risk for, lung cancer. As the number one cancer killer, lung cancer will kill more than 160,000 Americans this year alone, causing more deaths than breast, prostate, colon, liver, kidney cancers and melanoma combined.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Vitamin B12 can help in detecting cancers
6. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
7. Consensus on "Combination Therapy" for Breast Cancer
8. Cancers of Colon & Rectum linked to Cigarette Smoking
9. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
10. The Cancer Rumour mill working over time
11. Want skin cancer? Please have a cigarette
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
Breaking Medicine Technology: